Trexquant Investment LP Trims Holdings in Core Laboratories Inc. (NYSE:CLB)

Trexquant Investment LP lessened its stake in Core Laboratories Inc. (NYSE:CLB) by 34.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 102,951 shares of the oil and gas company’s stock after selling 54,470 shares during the period. Trexquant Investment LP owned about 0.22% of Core Laboratories worth $1,782,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Confluence Investment Management LLC grew its stake in Core Laboratories by 0.4% in the fourth quarter. Confluence Investment Management LLC now owns 136,359 shares of the oil and gas company’s stock worth $2,360,000 after purchasing an additional 599 shares in the last quarter. Isthmus Partners LLC grew its position in shares of Core Laboratories by 5.6% in the 4th quarter. Isthmus Partners LLC now owns 11,219 shares of the oil and gas company’s stock worth $194,000 after acquiring an additional 599 shares in the last quarter. Tidal Investments LLC increased its holdings in shares of Core Laboratories by 1.7% in the 3rd quarter. Tidal Investments LLC now owns 43,862 shares of the oil and gas company’s stock valued at $813,000 after acquiring an additional 716 shares during the last quarter. Smartleaf Asset Management LLC raised its position in shares of Core Laboratories by 173.8% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,037 shares of the oil and gas company’s stock valued at $35,000 after acquiring an additional 1,293 shares in the last quarter. Finally, Ridgewood Investments LLC lifted its stake in Core Laboratories by 4.6% during the fourth quarter. Ridgewood Investments LLC now owns 32,612 shares of the oil and gas company’s stock worth $565,000 after purchasing an additional 1,428 shares during the last quarter. 97.81% of the stock is owned by institutional investors and hedge funds.

Core Laboratories Trading Down 10.0 %

NYSE:CLB opened at $10.56 on Wednesday. The firm has a market capitalization of $493.22 million, a P/E ratio of 16.00, a P/E/G ratio of 0.99 and a beta of 1.99. The business has a 50 day simple moving average of $15.40 and a 200 day simple moving average of $17.83. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.32 and a quick ratio of 1.71. Core Laboratories Inc. has a 12-month low of $10.33 and a 12-month high of $25.13.

Core Laboratories (NYSE:CLB) last announced its quarterly earnings results on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.23. Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%. Equities research analysts predict that Core Laboratories Inc. will post 0.96 EPS for the current year.

Core Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, March 3rd. Stockholders of record on Monday, February 10th were issued a dividend of $0.01 per share. The ex-dividend date was Monday, February 10th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.38%. Core Laboratories’s dividend payout ratio (DPR) is presently 6.06%.

Analyst Ratings Changes

Separately, Citigroup raised shares of Core Laboratories from a “sell” rating to a “neutral” rating and increased their target price for the stock from $15.00 to $16.00 in a report on Wednesday, March 12th. One equities research analyst has rated the stock with a sell rating and four have given a hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $17.50.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.